These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7374355)

  • 21. Intraventricular administration of vasopressin and oxytocin effects the steady-state levels of serotonin, dopamine and norepinephrine in rat brain.
    Schwarzberg H; Kovács GL; Szabó G; Telegdy G
    Endocrinol Exp; 1981; 15(2):75-80. PubMed ID: 6973462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin and adrenalectomy-induced sensitivity to morphine.
    Ratka A; De Kloet ER
    Eur J Pharmacol; 1988 Aug; 153(1):65-71. PubMed ID: 3215278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethanol preference in homozygous diabetes insipidus (Brattleboro) rats: effect of vasopressin fragments.
    Rigter H; Crabbe J
    Ann N Y Acad Sci; 1982; 394():663-71. PubMed ID: 6960789
    [No Abstract]   [Full Text] [Related]  

  • 24. Actions of vasopressin-related peptides on glycogen metabolism in the perfused rat liver.
    Whitton PD; Hems DA
    Biochem Pharmacol; 1976 Feb; 25(4):405-7. PubMed ID: 181000
    [No Abstract]   [Full Text] [Related]  

  • 25. Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat.
    Baumeister AA; Anticich TG; Hawkins MF; Liter JC; Thibodeaux HF; Guillory EC
    Brain Res; 1988 Apr; 447(1):116-21. PubMed ID: 3382946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human pain thresholds after the application of lypressin, a vasopressin analogue.
    Kemppainen P; Pertovaara A; Huopaniemi T; Hämäläinen O; Grönblad M
    Pharmacol Toxicol; 1987 Jul; 61(1):16-9. PubMed ID: 3628176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of peripheral vasopressin 1A and oxytocin receptors on the subcutaneous vasopressin antinociceptive effects.
    Manzano-García A; González-Hernández A; Tello-García IA; Martínez-Lorenzana G; Condés-Lara M
    Eur J Pain; 2018 Mar; 22(3):511-526. PubMed ID: 29082571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin and terlipressin: pharmacology and its clinical relevance.
    Kam PC; Williams S; Yoong FF
    Anaesthesia; 2004 Oct; 59(10):993-1001. PubMed ID: 15488059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pituitary ACTH responsiveness in the vasopressin deficient rat.
    Krieger DT; Liotta A
    Life Sci; 1977 Jan; 20(2):327-35. PubMed ID: 190509
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of vasopressin analogue, desglycinamide lysine vasopressin, on changes in hippocampal monoamine metabolism associated with passive avoidance and amnesia in the rat [proceedings].
    Leonard BE; Ramaekers F; Rigter H
    Act Nerv Super (Praha); 1977 May; 19(2):160-2. PubMed ID: 18873
    [No Abstract]   [Full Text] [Related]  

  • 31. Intracerebroventricular naloxone produces a dose-dependent, monotonic increase in nociceptive threshold in the rat.
    Miaskowski C; Taiwo YO; Levine JD
    Brain Res; 1990 May; 515(1-2):323-5. PubMed ID: 2357571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naloxone effects on blood pressure, analgesia and diuresis in spontaneous hypertensive and normotensive rats.
    Delbarre B; Casset-Senon D; Delbarre G; Sestillange P; Christin O
    Neurosci Lett; 1982 May; 30(2):167-72. PubMed ID: 7110629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of lysine-vasopressin upon short-term recall of a noxious significance.
    Frucht-Celaru M; Sterescu-Volanschi M
    Physiologie; 1975; 12(4):285-9. PubMed ID: 814562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesia induced in vivo by central administration of enkephalin in rat.
    Belluzzi JD; Grant N; Garsky V; Sarantakis D; Wise CD; Stein L
    Nature; 1976 Apr; 260(5552):625-6. PubMed ID: 1264229
    [No Abstract]   [Full Text] [Related]  

  • 35. Naloxone effects on plasma vasopressin and oxytocin concentrations elevated by histamine, nicotine, isoproterenol and an acute increase in [NaCl] in cerebrospinal fluid.
    Summy-Long JY; Denlinger C; Palm D; Hartman RD; Rosella-Dampman LM
    Neuroendocrinology; 1986; 44(2):157-62. PubMed ID: 3796791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasopressin inhibits cyclic AMP accumulation and adenylate cyclase activity in cerebral preparations.
    Newman ME
    FEBS Lett; 1985 Feb; 181(2):203-6. PubMed ID: 2982658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RO 15-1788 produces naloxone-reversible analgesia in the rat.
    Davidovich S; Niv D; Geller E; Urca G
    Eur J Pharmacol; 1988 Jan; 146(1):175-9. PubMed ID: 3127226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of surfactant secretion by vasopressin in primary cultures of adult rat type II pneumocytes.
    Brown LA; Wood LH
    Biochim Biophys Acta; 1989 Jan; 1001(1):76-81. PubMed ID: 2912496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of physiological doses of vasopressin and oxytocin on avoidance and exploratory behaviour in rats.
    Schultz H; Kovács GL; Telegdy G
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):211-5. PubMed ID: 4471267
    [No Abstract]   [Full Text] [Related]  

  • 40. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular beta-endorphin and morphine in rats.
    Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 1985 Jan; 232(1):74-9. PubMed ID: 3155550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.